The test will allow large-scale monitoring of a population’s immunity and the effectiveness of vaccines, Mount Sinai said June 14. The test measures T-cell activation and takes less than 24 hours.
“We know that vulnerable populations don’t always mount an antibody response, so measuring T-cell activation is critical to assess the full extent of a person’s immunity,” Ernesto Guccione, PhD, one of the study’s senior authors and an oncology and pharmacology professor at Mount Sinai’s Tisch Cancer Institute, said in a news release. “Additionally, the emergence of SARS-CoV-2 variants like omicron, which evade most of the neutralizing ability of antibodies, points to the need for assays that can measure T cells, which are more effective against emerging variants of concern.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
